Neurobiology of Aging
Volume 28, Issue 9 , Pages 1307-1315 , September 2007

White matter grade and ventricular volume on brain MRI as markers of longevity in the cardiovascular health study

  • Lewis H. Kuller

      Affiliations

    • Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, 130 N. Bellefield Ave., Rm. 550, Pittsburgh, PA 15213, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 412 383 1895; fax: +1 412 383 1956.
    • ,
  • Alice M. Arnold

      Affiliations

    • Department of Biostatistics, University of Washington, Seattle, WA, United States
    • ,
  • W.T. Longstreth Jr.

      Affiliations

    • Department of Neurology, University of Washington, Seattle, WA, United States
    • Department of Epidemiology, University of Washington, Seattle, WA, United States
    • ,
  • Teri A. Manolio

      Affiliations

    • Division of Epidemiology and Clinical Applications, National Heart, Lung, and Blood Institute, Bethesda, MD, United States
    • ,
  • Daniel H. O’Leary

      Affiliations

    • Department of Radiology, Tufts-New England Medical Center, Boston, MA, United States
    • ,
  • Gregory L. Burke

      Affiliations

    • Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, United States
    • ,
  • Linda P. Fried

      Affiliations

    • Center on Aging and Health, Department of Medicine, Johns Hopkins University, Baltimore, MD, United States
    • Center on Aging and Health, Department of Epidemiology, Johns Hopkins University, Baltimore, MD, United States
    • ,
  • Anne B. Newman

      Affiliations

    • Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, United States

Received 24 January 2006 ,Revised 29 March 2006 ,Accepted 2 June 2006.

References 

  1. Atwood LD, Wolf PA, Heard-Costa NL, Massaro JM, Beiser A, D’Agostino RB, et al. Genetic variation in white matter hyperintensity volume in the Framingham Study. Stroke. 2004;35:1609–1613
  2. Barber R, Scheltens P, Gholkar A, Ballard C, McKeith I, Ince P, et al. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular disease and normal aging. J Neurol Neurosurg Psychiatry. 1999;67:66–72
  3. Beauchamp N, Kuller L, Lopez O, Jagust W. The relationship of MRI to dementia in the Cardiovascular Health Study. Neurobiol Aging. 2002;23(1):S54;[abstract #210]
  4. Breteler MM, van Swieten JC, Bots ML, Grobbee DE, Claus JJ, van den Hout JH, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology. 1994;44:1246–1252
  5. Bryan RN, Manolio TA, Schertz LD, Jungreis C, Poirier VC, Elster AD, et al. A method for using MR to evaluate effects of cardiovascular disease on the brain: the Cardiovascular Health Study. Am J Neuroradiol. 1994;15:1625–1633
  6. Bryan RN, Wells SW, Miller TJ, Elster AD, Jungreis CA, Poirier VC, et al. Infarctlike lesions in the brain: prevalence and anatomic characteristics at MR imaging of the elderly-data from the Cardiovascular Health Study. Radiology. 1997;202:47–54
  7. Carmelli D, DeCarli C, Swan GE, Jack LM, Reed T, Wolf PA, et al. Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. Stroke. 1998;29:1177–1181
  8. Chan D, Janssen JC, Whitwell JL, Watt HC, Jenkins R, Frost C, et al. Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study. Lancet. 2003;362:1121–1122
  9. DeCarli C, Haxby JV, Gillette JA, Teichberg D, Rapoport SI, Schapiro MB. Longitudinal changes in lateral ventricular volume in patients with dementia of the Alzheimer type. Neurology. 1992;42:2029–2036
  10. Dufouil C, et al. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke. The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) magnetic resonance imaging substudy. Circulation. 2005;112:1644–1650
  11. Fazekas F, Schmidt R, Scheltens P. Pathophysiologic mechanisms in the development of age-related white matter changes of the brain. Dement Geriatr Cogn Disord. 1998;9:2–5
  12. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1 5T in Alzheimer's dementia and moral aging. Am J Neuroradiol. 1987;8:421–426
  13. Filley CM. White matter and behavioral neurology. Ann NY Acad Sci. 2005;1064:162–183
  14. Forette F, et al. Prevention of dementia in randomized double blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998;352:1347–1351
  15. Fried LP, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;1:263–276
  16. Gold G, Kövari E, Herrmann FR, Canuto A, Hof PR, Michel J-P, et al. Cognitive consequences of thalamic, basal ganglia, and deep white matter lacunes in brain aging and dementia. Stroke. 2005;36:1184–1188
  17. Gootjes L, Teipel SJ, Zebuhr Y, Schwarz R, Leinsinger G, Scheltens P, et al. Regional distribution of white matter hyperintensities in vascular dementia Alzheimer's disease and healthy aging. Dement Geriatr Cogn Disord. 2004;18:180–188
  18. Gorelick PB. Prevention. In:  Erkinjuntti T,  Gaouthier S editor. Vascular cognitive impairment. London: Martin Dunitz Ltd.; 2002;p. 571–586
  19. Heckbert SR, Longstreth WT, Psaty BM, Murros KE, Smith NL, Newman AB, et al. The association of antihypertensive agents with MRI white matter findings and with modified Mini-Mental State Examination in older adults. J Am Geriatr Soc. 1997;45:1423–1433
  20. Inzitari D. Leukoaraiosis: an independent risk factor for stroke?. Stroke. 2003;34:2067–2071
  21. Ives DG, Bild DE, Psaty BM, Kuller LH, Crowley PM, Cruise RG, et al. Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol. 1995;5:278–285
  22. Kuller L, Borhani N, Furberg C, Gardin J, Manolio T, O’Leary D, et al. Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. Am J Epidemiol. 1994;139:1164–1179
  23. Kuller LH, et al. White matter hyperintensity on cranial magnetic resonance imaging. A predictor of stroke. Stroke. 2004;34:1821–1825
  24. Kuller LH, Lopez OL, Jagust WJ, Becker JT, DeKosky ST, Lyketsos C, et al. Determinants of vascular dementia in the Cardiovascular Health Cognition Study. Neurology. 2005;64:1548–1552
  25. Kuller LH, Lopez OL, Newman A, Beauchamp NJ, Burke G, Dulberg C, et al. Risk factors for dementia in the Cardiovascular Health Cognition Study. Neuroepidemiology. 2003;22:13–22
  26. Kuller LH, Lopez OL. Commentary. Treatment of hypertension and prevention of dementia. Alzheimers Dement. 2005;1:38–40
  27. Launer LJ, et al. Regional variability in the prevalence of cerebral white matter lesions: an MRI study in 9 European countries (CASCADE). Neuroepidemiology. 2006;26:23–29
  28. Leblanc GG, Meschia JF, Stuss DT, Hachinski V. Genetics of vascular cognitive impairment. The opportunity and the challenges. Stroke. 2006;37:248–255
  29. Longstreth WT, Arnold AM, Beauchamp NJ, Manolio TA, Lefkowitz D, Jungreis C, et al. Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly. The Cardiovascular Health Study. Stroke. 2005;36:56–61
  30. Longstreth WT, et al. Clinical correlates of ventricular and sulcal size on cranial magnetic resonance imaging of 3,301 elderly people. The Cardiovascular Health Study. Neuroepidemiology. 2000;19:30–42
  31. Longstreth WT, Diehr P, Beauchamp NJ, Manolio TA. Patterns on cranial magnetic resonance imaging in elderly people and vascular disease outcomes. Arch Neurol. 2001;58:2074
  32. Longstreth WT, et al. Cluster analysis and patterns of findings on cranial magnetic resonance imaging of the elderly. The Cardiovascular Health Study. Arch Neurol. 2001;58:635–640
  33. Longstreth WT, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke. 1996;27:1274–1282
  34. Lopez OL, Kuller LH, Ives D, Becker JT, Beauchamp N. Evaluation of dementia in the Cardiovascular Health Cognition Study. Neuroepidemiology. 2003;22:1–12
  35. Manolio T, et al. Relationship of cerebral MRI findings to ultrasonographic carotid atherosclerosis in older adults: the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 1999;19:356–365
  36. Manolio TA, Kronmal RA, Burke GL, Poirier V, O’Leary DH, Gardin JM, et al. Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study. Stroke. 1994;25:318–327
  37. Munoz D, Hastak SM, Harper B, Lee D, Hachinski VC. Pathological correlates of increased signals of the centrum semiovale on magnetic resonance imaging. Arch Neurol. 1993;50:492–497
  38. Najjar SS, Scuteri A, Lakatta EG. Arterial aging. Is it an immutable cardiovascular risk factor?. Hypertension. 2005;46:454–462
  39. Newman AB, et al. “Successful aging. ” Effect of subclinical disease. Arch Int Med. 2003;163:2315–2322
  40. O’Rourke MF, Nichols WW. Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension. Hypertension. 2005;45:652–658
  41. O’Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney. Cause and logic of therapy. Hypertension. 2005;46:200–204
  42. Pantoni L, et al. Impact of age-related cerebral white matter changes on the transition to disability—the LADIS Study: rationale, design and methodology. Neuroepidemiology. 2005;24:51–62
  43. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis. Stroke. 1997;28:652–659
  44. Price TR, Psaty B, O’Leary D, Burke G, Gardin J for the Cardiovascular Health Study Research Group. Assessment of cerebrovascular disease in the Cardiovascular Health Study. Ann Epidemiol. 1993;3:504–507
  45. Psaty BM, Kuller LH, Bild D, Burke GL, Kittner SJ, Mittelmark M, et al. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol. 1995;5:270–277
  46. Roher AE, Esh C, Kokjohn TA, Kalback W, Luehrs DC, Seward DJ, et al. Circle of Willis atherosclerosis is a risk factor for sporadic Alzheimer's disease. Arterioscler Thromb Vasc Biol. 2003;23:2055–2062
  47. Roman GC. Stroke, cognitive decline and vascular dementia: the silent epidemic of the 21st century. Neuroepidemiology. 2003;22:161–164
  48. Rosano C, Becker J, Lopez O, Lopez-Garcia P, Carter CS, Newman A, et al. Morphometric analysis of gray matter volume in demented older adults: exploratory analysis of the Cardiovascular Health Study brain MRI database. Neuroepidemiology. 2005;24:221–229
  49. Rosano C, Kuller L, Arnold A, Longstreth WT, Newman AB. Subclinical brain MRI abnormalities predict physical functional decline in older adults. J Am Geriatr Soc. 2005;53:649–654[abstract #A33]
  50. Schiffrin EL. Blood pressure lowering in PROGRESS (Perindopril Protection Against Recurrent Stroke Study) and white matter hyperintensities. Should this progress matter to patients?. Circulation. 2005;112:1525–1526
  51. Schmidt R, Ropele S, Enzinger C, Petrovic K, Smith S, Schmidt H, et al. White matter lesion progression, brain atrophy, and cognitive decline: the Austrian Stroke Prevention Study. Ann Neurol. 2005;58:610–616
  52. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005;352:2049–2060
  53. Starr JM, Leaper SA, Murray AD, Lemmon HA, Staff RT, Deary IJ, et al. Brain white matter lesions detected by magnetic resonance imaging are associated with balance and gait speed. J Neurol Neurosurg Psychiatry. 2003;74:94–98
  54. Swan GE, DeCarli C, Miller BL, Reed T, Wolf PA, Carmelli D. Biobehavioral characteristics of nondemented older adults with subclinical brain atrophy. Neurology. 2000;54:2108–2114
  55. Turner ST, Jack CR, Fornage M, Mosley TH, Boerwinkle E, de Andrade M. Heritability of leukoaraiosis in hypertensive sibships. Hypertension. 2004;43:483–487
  56. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MMB. Silent brain infarcts and white matter lesions increase stroke risk in the general population. The Rotterdam Scan Study. Stroke. 2003;34:1126–1129
  57. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MMB. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348:1215–1222
  58. White L, Petrovitch H, Hardman J, Nelson J, Davis DG, Ross W, et al. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. In: de la Torre JC, Kalaria R, Nakajima K, Nagata K, editors. Alzheimer's disease. Vascular etiology and pathology. Ann NY Acad Sci 2002;977:9–23.
  59. Wu CC, Mungas D, Eberling JL, Reed BR, Jagust WJ. Imaging interactions between Alzheimer's disease and cerebrovascular disease. In: de la Torre JC, Kalaria R, Nakajima K, Nagata K, editors. Alzheimer's disease. Vascular etiology and pathology. Ann NY Acad Sci 2002; 977:403–15.
  60. Yue NC, Arnold AM, Longstreth WT, Elster AD, Jungreis CA, O’Leary DH, et al. Sulcal, ventricular, and white matter changes at MR imaging in the aging brain: data from the Cardiovascular Health Study. Radiology. 1997;202:33–39
  61. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol. 2005;25:932–943

PII: S0197-4580(06)00196-5

doi: 10.1016/j.neurobiolaging.2006.06.010

Neurobiology of Aging
Volume 28, Issue 9 , Pages 1307-1315 , September 2007

Article Tools

* Image Usage & Resolution